Drugs / HydroLenz
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05592912 | Jan 2024 → Jan 2025 | — | PromiSight, LLC | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HydroLenz | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05592912 ↗ |